Safer to Use™ Breakable Extended Release Tablets for Precise Titration
Value Drivers: Differentiated Value-Added Drugs
The new labelling that Flexitab products obtain, describing the safe breakability of the tablets, prevents interchangeability (substitution) with non-breakable extended products. Flexitab provides clinically and medically relevant differentiation for existing immediate release and extended-release products in addition to the convenience of an extended release product.
Many Flexitab products can be approved on the basis of pharmacokinetic studies alone. Flexitab avoids the costs of multiple tablet manufacturing from a simple direct compression process.
All Flexitab tablets fall under Altus global patent umbrella which provides protection to 2038.
Learn more about Altus Value Added Medicines